The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer. (2017)
Attributed to:
Identification, roles and mechanisms of long non-coding RNAs in stem cells and metastasis in breast cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-17-0081
PubMed Identifier: 28775148
Publication URI: http://europepmc.org/abstract/MED/28775148
Type: Journal Article/Review
Volume: 16
Parent Publication: Molecular cancer therapeutics
Issue: 10
ISSN: 1535-7163